Pharming Group NV
F:PHG
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Pharming Group NV
F:PHG
|
NL |
|
S
|
SSE PLC
XMUN:SCT
|
UK |
|
F
|
FTI Consulting Inc
F:FCQ
|
US |
Wall St Price Targets
PHG Price Targets Summary
Pharming Group NV
According to Wall Street analysts, the average 1-year price target for PHG is 21.49 EUR with a low forecast of 17.31 EUR and a high forecast of 25.99 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is PHG's stock price target?
Price Target
21.49
EUR
According to Wall Street analysts, the average 1-year price target for PHG is 21.49 EUR with a low forecast of 17.31 EUR and a high forecast of 25.99 EUR.
What is the Revenue forecast for Pharming Group NV?
Projected CAGR
17%
Over the last 14 years, the compound annual growth rate for Revenue has been 41%. The projected CAGR for the next 5 years is 17%.
What is the Operating Income forecast for Pharming Group NV?
Projected CAGR
35%
The compound annual growth rate for Operating Income over the next 5 years is 35%.
What is the Net Income forecast for Pharming Group NV?
Projected CAGR
130%
The compound annual growth rate for Net Income over the next 4 years is 130%.
